Skip to content

Red flags and safety concerns

TL;DR — A degenerative MRI must not obscure cancer, infection, fracture, inflammatory disease, cauda equina syndrome or major neurological compression. Individual red flags usually have limited diagnostic accuracy; combinations, baseline prevalence and clinical trajectory determine urgency (Downie 2013, PMID 24335669; Galliker 2020, PMID 31278933). New urinary retention, saddle sensory loss, rapidly progressive weakness, systemic illness or high-risk trauma requires urgent evaluation, not routine DDD care. Procedures add infection, bleeding, neurological, drug and implant risks that must be matched to phenotype and monitored longitudinally.

Red flag is a probability modifier

A red flag is not a diagnosis and absence of one flag is not a rule-out test. Reviews find many guideline lists contain items with weak empirical support (Verhagen 2016, PMID 27376890; Verhagen 2017, PMID 28708761).

Principle Application
Start with baseline prevalence Emergency, primary care and oncology differ
Use combinations One nonspecific symptom is weak
Consider severity/trajectory Rapid progression matters
Seek objective findings Neurology, fever, labs, imaging
Reassess over time Early disease may declare itself
Do not anchor on DDD Incidental degeneration is common

Cauda equina syndrome

Cauda equina syndrome (CES) is severe compression/dysfunction of lumbosacral roots, often from a large central herniation but also tumor, infection, hematoma or trauma.

Urgent features include:

  • urinary retention or impaired urinary sensation;
  • saddle/perineal sensory change;
  • bilateral or rapidly progressive leg deficits;
  • reduced anal tone or fecal dysfunction;
  • severe bilateral radicular symptoms with evolving neurology;
  • sexual dysfunction in an acute neurological pattern.
CES construct Description Safety implication
Suspected Concerning symptoms without objective confirmation Urgent assessment/MRI
Incomplete Altered urinary sensation/control before painless retention Time-critical pathway
Retention Painless retention/overflow with deficits Emergency decompression pathway

A systematic review estimated CES incidence but found heterogeneous denominators and definitions (Hoeritzauer 2020, PMID 32059184).

History and examination red flags have limited sensitivity and specificity against MRI (Dionne 2019, PMID 31132655). A normal single item should not override a coherent evolving syndrome.

Progressive neurological deficit

Finding Possible level/pathway Action
New foot drop L4/L5 root or peroneal nerve Urgent localization/imaging
Progressive quadriceps weakness L3/L4 root/femoral nerve Urgent assessment
Bilateral weakness Central canal/cord/systemic Emergency depending trajectory
Hyperreflexia/spasticity Cord/myelopathy Cervical/thoracic imaging pathway
Gait ataxia/hand dysfunction Cervical myelopathy Not explained by lumbar DDD
New bowel/bladder/saddle change Cauda equina/conus Emergency

Pain without objective deficit can still be severe; urgency is determined by neurological/systemic risk, not pain score alone.

Malignancy

Cancer history is one of the more informative red flags, while age, night pain and weight loss alone are weak (Henschke 2013, PMID 23450586; Downie 2013, PMID 24335669).

Clue Interpretation
Prior cancer Raises pre-test probability materially
Unexplained progressive pain Concerning in context
Systemic weight loss Nonspecific alone
Failure to improve Requires reassessment, not automatic MRI
Focal bony tenderness Nonspecific but relevant
Night pain Common in benign pain; pattern matters

Systematic review found many malignancy red flags in guidelines lack empirical support (Verhagen 2017, PMID 28708761). Clinical judgment should combine risk rather than count boxes.

Infection

Spinal infection includes discitis/osteomyelitis, epidural abscess and postoperative/procedural infection.

Risk factors:

  • fever or bacteremia;
  • immunosuppression;
  • injection drug use;
  • recent spinal injection/surgery;
  • indwelling vascular access;
  • diabetes or severe systemic illness;
  • recent infection;
  • escalating pain with inflammatory markers.

Red-flag review found the evidence base for early spinal infection screening is limited; no single feature reliably excludes infection (Yusuf 2019, PMID 31836000).

Modic type 1 can mimic or coexist with infection. Endplate destruction, paraspinal/epidural collection, systemic context and labs guide distinction.

Vertebral fracture

Higher-value fracture clues include significant trauma, prolonged corticosteroid use, older age, osteoporosis and contusion/abrasion; accuracy varies by setting (Williams 2013, PMID 23440831; Han 2023, PMID 37615643).

Risk context Imaging consideration
Major trauma Immediate trauma protocol
Minor trauma plus osteoporosis Low threshold for radiograph/CT/MRI
Steroid exposure Compression-fracture risk
Older age with acute onset Combine with exam/history
Cancer/infection risk Pathological fracture differential

Cochrane review continues to find limited accuracy for many individual red flags, emphasizing combinations (Williams 2023, PMID 38014846).

Prospective MRI assessment in older women with acute low-back pain found occult vertebral fractures can be missed by initial clinical assessment, supporting a lower imaging threshold in a high-risk phenotype rather than universal imaging (Terakado 2017, PMID 28630567).

Inflammatory disease

Inflammatory back pain and axial spondyloarthritis should be considered with young onset, prolonged morning stiffness, improvement with activity, alternating buttock pain, uveitis, psoriasis, inflammatory bowel disease or family history.

Degenerative findings can coexist and should not terminate assessment. Normal inflammatory markers do not exclude axial spondyloarthritis.

Referred visceral and vascular pain

Source Clues Emergency concern
Aortic Sudden severe back/abdominal pain, vascular findings Aneurysm/dissection
Renal/ureteric Flank/groin, urinary symptoms Sepsis/obstruction
Pancreatic/GI Abdominal symptoms, meals, systemic illness Acute abdomen
Pelvic/gynecologic Pelvic/cyclic symptoms, pregnancy Ectopic/hemorrhage/infection
Vascular claudication Exertional, pulse changes Critical ischemia

Incidental lumbar degeneration does not reduce visceral risk.

Imaging safety and incidental harm

MRI has no ionizing radiation but can identify common incidental findings. CT and radiography add radiation; contrast has kidney/allergy considerations; implants and foreign bodies affect MRI safety.

Potential harms of low-value imaging:

  • deterministic diagnostic labeling;
  • cascade to injections or surgery;
  • duplicated scans;
  • anxiety and activity avoidance;
  • detection of findings unrelated to symptoms;
  • cost and delayed active care.

Asymptomatic prevalence data provide the quantitative basis for cautious interpretation (Brinjikji 2015, PMID 25430861).

Medicine safety

Medicine Major concern Monitoring/mitigation
NSAIDs GI bleed, renal injury, BP/CV risk Dose/duration and comorbidity review
Acetaminophen Hepatotoxicity Total daily dose and combination products
Muscle relaxants Sedation, falls Short duration; driving warning
Duloxetine Nausea, BP, withdrawal, interactions Gradual change and interaction check
Gabapentinoids Sedation, edema, misuse Phenotype and renal dosing
Opioids Overdose, dependence, constipation, endocrine/sleep effects Functional target, dose review, naloxone context
Steroids Glucose, infection, bone effects Cumulative exposure

Pharmacologic benefits are generally small and evidence certainty limited (Chou 2017, PMID 28192790; Cashin 2023, PMID 37014979).

Abrupt opioid or antidepressant discontinuation can cause withdrawal and harm.

Epidural and intradiscal injection safety

Hazard Epidural Intradiscal
Infection Epidural abscess/meningitis Discitis
Bleeding Epidural hematoma Local/retroperitoneal
Dural puncture Possible Less typical
Neurological injury Vascular/direct/root Needle/product extrusion
Steroid systemic effect Yes If steroid used
Tissue injury Procedure-related Needle puncture can damage disc

Transforaminal injection has rare catastrophic vascular risk; image guidance and formulation choices matter. Evidence supports only small short-term radicular benefit (Shamliyan 2014, PMID 24787344).

Basivertebral ablation safety

Trial populations excluded many high-risk anatomical and clinical conditions. Potential harms include transient radicular symptoms, pedicle breach, bleeding, infection and vertebral fracture.

Generalizing safety estimates to osteoporosis, extensive prior surgery or anatomy outside trial criteria is inappropriate (Fischgrund 2018, PMID 29423885; Khalil 2019, PMID 31229663).

Fusion safety

Phase Risks
Intraoperative Vascular/visceral/nerve injury, blood loss, dural tear
Early postoperative Infection, thromboembolism, ileus, readmission
Healing Nonunion, hardware failure, persistent pain
Late Adjacent disease, junctional failure, reoperation

Outcome meta-analysis shows substantial average improvement but persistent disability and complications remain (Koenders 2019, PMID 29995169). Smoking, diabetes, bone health and frailty require optimization.

Disc-replacement safety

Approach risks include vascular and sympathetic/autonomic injury; device risks include migration, subsidence, wear, heterotopic ossification, facet degeneration and difficult revision (Janssen 2017, PMID 29176486).

Five-year trial results cannot establish lifetime implant safety (Zigler 2012, PMID 23082846; Radcliff 2018, PMID 28005616).

Biologic and regenerative safety

Potential risks include:

  • contamination and discitis;
  • immune reaction;
  • ectopic tissue or bone;
  • tumorigenicity;
  • product extrusion;
  • neurological injury;
  • unregulated manufacturing;
  • financial exploitation.

A case of diffuse hyperplastic gliosis causing cauda equina after stem-cell injection demonstrates that “autologous” or “regenerative” is not synonymous with safe (Aoun 2019, PMID 31491761).

Regulated trials need long-term surveillance beyond early pain outcomes (Navani 2019, PMID 30717500).

Exercise and activity safety

Exercise is generally safe in nonspecific chronic low-back pain when progressive and adapted. New neurological deficits, systemic illness or fracture risk require modification. Pain during activity is not automatically tissue damage, but rapidly escalating or prolonged unusual symptoms warrant reassessment.

Running review did not support a simple claim that running uniformly damages discs, though evidence is heterogeneous (Shu 2024, PMID 38204324).

Post-procedure and post-surgical warning signs

Urgent reassessment after intervention for:

  • fever, wound drainage or escalating focal pain;
  • new weakness, saddle change or bladder dysfunction;
  • severe positional headache after possible dural puncture;
  • chest pain, dyspnea or unilateral swelling;
  • sudden severe back/abdominal pain;
  • new deformity or trauma;
  • uncontrolled pain with systemic signs.

Safety-net documentation

Item Document
Current neurological baseline Strength, sensation, reflexes, gait
Red-flag review Present/absent/context
Expected course What improvement/fluctuation is typical
Escalation trigger Specific symptoms and route
Medicine plan Dose, duration, stop rule
Procedure consent Benefit, alternatives, common/serious harms
Follow-up Time and responsible clinician

Evidence deepening: discriminating findings (2026-08-30)

The added evidence below was selected to change interpretation, not merely increase citation count. Each result is kept within its studied phenotype and design.

Evidence Quantified or mechanistic finding Consequence for interpretation
International Framework for Red Flags for Potential Serious Spinal Pathologies (Finucane 2020, PMID 32438853) An international framework organizes serious spinal pathology screening around evidence-informed clinical reasoning rather than a memorized undifferentiated red-flag list. Escalation depends on combinations, baseline risk and evolution.
A systematic review identifies five "red flags" to screen for vertebral fracture in patients with low back pain (Henschke 2008, PMID 18177783) A fracture review found major trauma had LR+ 12.8; age over 50 had LR+ 2.2 and LR− 0.34; female sex had LR+ 2.3. Red flags have unequal diagnostic weight and weak items should not trigger automatic imaging alone.
Diagnostic Utility of Red Flags for Detecting Spinal Malignancies in Patients with Low Back Pain: A Scoping Review (Notarangelo 2025, PMID 41156041) A malignancy scoping review of 70 studies found cancer prevalence among low-back-pain cohorts ranged from 0.1% to 1.6%. Low baseline prevalence magnifies false positives from nonspecific red flags.
A prospective study of the role of bladder scanning and post-void residual volume measurement in improving diagnostic accuracy of cauda equina syndrome (Katzouraki 2020, PMID 32475252) Among 260 suspected cauda-equina referrals, bilateral sciatica sensitivity was 32.4% and PPV 17.2%; post-void residual ≥200 mL predicted MRI compression more accurately. No bladder threshold safely replaces history, examination and urgent MRI when suspicion remains.
The influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review (Filley 2024, PMID 38962714) A review of 71 studies and 12,278 patients linked osteoporosis with mechanical complications after lumbar fusion. Bone health is a modifiable perioperative risk domain, not an incidental comorbidity.
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study) (Pers 2024, PMID 39393844) In the placebo-controlled RESPINE trial, 20 million allogeneic marrow stromal cells failed to separate clearly from sham on the co-primary clinical responder endpoint. Procedural and biologic harms must be justified against controlled, product-specific efficacy—not uncontrolled improvement.

Controversy carried forward

These additions narrow several claims but do not create a diagnostic gold standard. Where an imaging, molecular or treatment-response signal conflicts with sham-controlled, longitudinal or population evidence, the conflict is retained as a selection and transportability problem rather than resolved by vote.

Open questions

  • Which red-flag combinations provide reliable actionable probabilities in primary care and emergency settings? (Galliker 2020, PMID 31278933)
  • Can CES definitions and time-to-treatment outcomes be standardized? (Hoeritzauer 2020, PMID 32059184)
  • How should late cell/device harms be captured across national registries? (Aoun 2019, PMID 31491761)
  • What imaging-report interventions reduce incidental-harm cascades? (Brinjikji 2015, PMID 25430861)
  • Which patients outside trial criteria have acceptable BVN-ablation safety? (Khalil 2019, PMID 31229663)

References

  1. Downie A, Williams CM, Henschke N, et al. Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ (Clinical research ed.). 2013;347:f7095. PMID 24335669
  2. Galliker G, Scherer DE, Trippolini MA, et al. Low Back Pain in the Emergency Department: Prevalence of Serious Spinal Pathologies and Diagnostic Accuracy of Red Flags. The American journal of medicine. 2020;133(1):60-72.e14. PMID 31278933
  3. Verhagen AP, Downie A, Popal N, et al. Red flags presented in current low back pain guidelines: a review. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2016;25(9):2788-802. PMID 27376890
  4. Verhagen AP, Downie A, Maher CG, et al. Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review. Pain. 2017;158(10):1860-1868. PMID 28708761
  5. Hoeritzauer I, Wood M, Copley PC, et al. What is the incidence of cauda equina syndrome? A systematic review. Journal of neurosurgery. Spine. 2020;32(6):832-841. PMID 32059184
  6. Dionne N, Adefolarin A, Kunzelman D, et al. What is the diagnostic accuracy of red flags related to cauda equina syndrome (CES), when compared to Magnetic Resonance Imaging (MRI)? A systematic review. Musculoskeletal science & practice. 2019;42:125-133. PMID 31132655
  7. Henschke N, Maher CG, Ostelo RW, et al. Red flags to screen for malignancy in patients with low-back pain. The Cochrane database of systematic reviews. 2013;2013(2):CD008686. PMID 23450586
  8. Yusuf M, Finucane L, Selfe J. Red flags for the early detection of spinal infection in back pain patients. BMC musculoskeletal disorders. 2019;20(1):606. PMID 31836000
  9. Williams CM, Henschke N, Maher CG, et al. Red flags to screen for vertebral fracture in patients presenting with low-back pain. The Cochrane database of systematic reviews. 2013. PMID 23440831
  10. Han CS, Hancock MJ, Downie A, et al. Red flags to screen for vertebral fracture in people presenting with low back pain. The Cochrane database of systematic reviews. 2023;8(8):CD014461. PMID 37615643
  11. Williams CM, Henschke N, Maher CG, et al. Red flags to screen for vertebral fracture in patients presenting with low-back pain. The Cochrane database of systematic reviews. 2023;11(11):CD008643. PMID 38014846
  12. Terakado A, Orita S, Inage K, et al. A Clinical Prospective Observational Cohort Study on the Prevalence and Primary Diagnostic Accuracy of Occult Vertebral Fractures in Aged Women with Acute Lower Back Pain Using Magnetic Resonance Imaging. Pain research & management. 2017;2017:9265259. PMID 28630567
  13. Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR. American journal of neuroradiology. 2015;36(4):811-6. PMID 25430861
  14. Chou R, Deyo R, Friedly J, et al. Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Annals of internal medicine. 2017;166(7):480-492. PMID 28192790
  15. Cashin AG, Wand BM, O'Connell NE, et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. The Cochrane database of systematic reviews. 2023;4(4):CD013815. PMID 37014979
  16. Shamliyan TA, Staal JB, Goldmann D, et al. Epidural steroid injections for radicular lumbosacral pain: a systematic review. Physical medicine and rehabilitation clinics of North America. 2014;25(2):471-89.e1-50. PMID 24787344
  17. Fischgrund JS, Rhyne A, Franke J, et al. Intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: a prospective randomized double-blind sham-controlled multi-center study. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2018;27(5):1146-1156. PMID 29423885
  18. Khalil JG, Smuck M, Koreckij T, et al. A prospective, randomized, multicenter study of intraosseous basivertebral nerve ablation for the treatment of chronic low back pain. The spine journal : official journal of the North American Spine Society. 2019;19(10):1620-1632. PMID 31229663
  19. Koenders N, Rushton A, Verra ML, et al. Pain and disability after first-time spinal fusion for lumbar degenerative disorders: a systematic review and meta-analysis. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2019;28(4):696-709. PMID 29995169
  20. Janssen M, Garcia R, Miller L, et al. Challenges and Solutions for Lumbar Total Disc Replacement Implantation. Spine. 2017;42 Suppl 24:S108-S111. PMID 29176486
  21. Zigler JE, Delamarter RB. Five-year results of the prospective, randomized, multicenter, Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential arthrodesis for the treatment of single-level degenerative disc disease. Journal of neurosurgery. Spine. 2012;17(6):493-501. PMID 23082846
  22. Radcliff K, Spivak J, Darden B, et al. Five-Year Reoperation Rates of 2-Level Lumbar Total Disk Replacement Versus Fusion: Results of a Prospective, Randomized Clinical Trial. Clinical spine surgery. 2018;31(1):37-42. PMID 28005616
  23. Aoun SG, Peinado Reyes V, El Ahmadieh TY, et al. Stem cell injections for axial back pain: a systematic review of associated risks and complications with a case illustration of diffuse hyperplastic gliosis resulting in cauda equina syndrome. Journal of neurosurgery. Spine. 2019;31(6):906-913. PMID 31491761
  24. Navani A, Manchikanti L, Albers SL, et al. Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain physician. 2019;22(1S):S1-S74. PMID 30717500
  25. Shu D, Dai S, Wang J, et al. Impact of Running Exercise on Intervertebral Disc: A Systematic Review. Sports health. 2024;16(6):958-970. PMID 38204324
  26. Finucane LM, Downie A, Mercer C, Greenhalgh SM, Boissonnault WG, Pool-Goudzwaard AL, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. The Journal of orthopaedic and sports physical therapy. 2020;50(7):350-372. PMID 32438853
  27. Henschke N, Maher CG, Refshauge KM. A systematic review identifies five "red flags" to screen for vertebral fracture in patients with low back pain. Journal of clinical epidemiology. 2008;61(2):110-118. PMID 18177783
  28. Notarangelo G, Margelli M, Giovannico G, Bruno F, Milella C, Feller D, et al. Diagnostic Utility of Red Flags for Detecting Spinal Malignancies in Patients with Low Back Pain: A Scoping Review. Journal of clinical medicine. 2025;14(20):7174. PMID 41156041
  29. Katzouraki G, Zubairi AJ, Hershkovich O, Grevitt MP. A prospective study of the role of bladder scanning and post-void residual volume measurement in improving diagnostic accuracy of cauda equina syndrome. The bone & joint journal. 2020;102-B(6):677-682. PMID 32475252
  30. Filley A, Baldwin A, Ben-Natan AR, Hansen K, Arora A, Xiao A, et al. The influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review. North American Spine Society journal. 2024;18:100327. PMID 38962714
  31. Pers YM, Soler-Rich R, Vadalà G, Ferreira R, Duflos C, Picot MC, et al. Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study). Annals of the rheumatic diseases. 2024;83(11):1572-1583. PMID 39393844